Orthofix Medical (OFIX) Free Cash Flow (2010 - 2026)

Orthofix Medical has disclosed Free Cash Flow across 17 years of filings, most recently posting -$28.3 million for Q1 2026.

• Quarterly Free Cash Flow fell 12.51% year-over-year to -$28.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.4 million (up 7.87% YoY) and the FY2025 annual result came in at -$1.3 million, up 85.92% from the prior year.
• Free Cash Flow fell to -$28.3 million in Q1 2026, from $16.8 million in the prior quarter.
• Over five years, Free Cash Flow peaked at $16.8 million in Q4 2025 and troughed at -$45.5 million in Q1 2023.
• A 5-year average of -$10.7 million and a median of -$10.6 million in 2022 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 577.65% — and 2025, when it jumped 718.85%.
• Tracing OFIX's Free Cash Flow over 5 years: stood at -$4.7 million in 2022, then sank by 395.36% to -$23.0 million in 2023, then jumped by 165.94% to $15.2 million in 2024, then grew by 10.67% to $16.8 million in 2025, then slumped by 268.08% to -$28.3 million in 2026.
• Business Quant data shows OFIX's Free Cash Flow at -$28.3 million in Q1 2026, $16.8 million in Q4 2025, and $2.5 million in Q3 2025.